Biden Administration Backs Vaccine Intellectual Property Waiver

The move, which is not supported by the pharmaceutical industry, would allow other countries to design and manufacture COVID-19 vaccines without fear of litigation.
Source: The Scientist - Category: Science Tags: News & Opinion Source Type: news
More News: COVID-19 | Science | Vaccines